Anxiety and post-traumatic stress disorder in cardiac patients by Copeland, C. et al.
Copeland, C., Joekes, K. & Ayers, S. (2011). Anxiety and post-traumatic stress disorder in cardiac 
patients. British Journal of Wellbeing, 2(1), 15 - 19.
City Research Online
Original citation: Copeland, C., Joekes, K. & Ayers, S. (2011). Anxiety and post-traumatic stress 
disorder in cardiac patients. British Journal of Wellbeing, 2(1), 15 - 19.
Permanent City Research Online URL: http://openaccess.city.ac.uk/1993/
 
Copyright & reuse
City  University  London has developed City  Research Online  so that  its  users  may access the 
research outputs of City University London's staff. Copyright © and Moral Rights for this paper are 
retained by the individual author(s) and/ or other copyright holders.  All material in City Research 
Online is checked for eligibility for copyright before being made available in the live archive. URLs 
from City Research Online may be freely distributed and linked to from other web pages. 
Versions of research
The version in City Research Online may differ from the final published version. Users are advised to 
check the Permanent City Research Online URL above for the status of the paper.
Enquiries
If you have any enquiries about any aspect of City Research Online, or if you wish to make contact  
with the author(s) of this paper, please email the team at publications@city.ac.uk.
  
 
 
 
 
Anxiety and post-traumatic stress disorder in cardiac patients 
 
 
 
Dr Claire Copland, Consultant Clinical Psychologist, St George’s Healthcare Trust, Wolfson Centre, 
Wimbledon, London. 
 
Dr Katherine Joekes, Lecturer in Clinical Communication, St George’s Hospital, University of London.   
 
Dr Susan Ayers, Senior Lecturer in Health Psychology, School of Psychology, University of Sussex 
 
 
Reference  
Copeland, C., Joekes, K., & Ayers, S. (2011). Anxiety and post-traumatic stress disorder in cardiac 
patients. British Journal of Wellbeing, 2(1), 15-19. 
 
 
 
 
 
 
Key Points 
 Approximately 50% of cardiac patients may have symptoms of anxiety and 25% have anxiety 
disorders 
 Anxiety can affect the development of heart disease, further morbidity, healthcare use and 
possibly rehabilitation 
 Post-traumatic stress disorder (PTSD) is an anxiety disorder and occurs in approximately 
15% of people after sudden cardiac events such as myocardial infarction or cardiac arrest. A 
further 18% may have subclinical symptoms of PTSD 
 PTSD symptoms are associated in a dose-response manner to cardiac morbidity and 
mortality, even after taking into account usual cardiac risk factors 
 Cardiac care therefore should include screening and management of anxiety and PTSD. 
 
 
Introduction 
Although regarded as a psychological condition, anxiety has a strong physiological component 
through activation of the sympathetic branch of the autonomic nervous system.  Anxiety can be 
accompanied by symptoms such as a racing heart, palpitations and breathlessness.  Due to the 
similarity between anxiety symptoms and cardiac problems, anxiety is a common concern for cardiac 
patients.  Approximately 50% of cardiac patients report symptoms of anxiety after acute cardiac 
events and approximately 25% have anxiety disorders (Crowe et al, 1996; Januzzi et al, 2000).  
These statistics are significant as anxiety is thought to play a role in heart disease in a number of 
ways, including -  
 The development of heart disease 
 Further morbidity and prognosis 
 Health-care use and attendance 
 Ability to modify lifestyle and engage in rehabilitation.  
 
The link between anxiety and the development of heart disease is now well established. A systematic 
review of prospective studies of healthy samples concluded that anxious people are between 2.4 and 
7.8 times more likely to develop heart disease (Suls and Bunde, 2005). Evidence for the effect of 
anxiety on prognosis in patients with existing heart disease is less consistent; the same review 
concluded that the majority of research finds no relationship between anxiety and mortality in cardiac 
patients (Suls and Bunde, 2005).  However, anxiety might affect further morbidity. Research suggests 
anxious patients are one to five times more likely to experience nonfatal myocardial infarction (MI), 
new onset or recurrent ischaemia, ventricular tachycardia, congestive heart failure and unstable 
angina (Frasure-Smith et al, 1995; Moser and Dracup, 1996; Denollet and Brutsaert, 2000). The effect 
of anxiety on cardiac morbidity appears to be independent of depression (Huffman et al, 2008).  
 
Anxiety is associated with a focus on threat-related stimuli. In people with heart disease, anxiety may 
lead to an increased focus on cardiac and other physical symptoms, prompting increased healthcare 
use.  For example, Karsdorp et al (2009) found that when people were given false information about 
irregular heart beat, anxious patients were more likely to interpret this as a symptom of cardiac 
problems than non-anxious patients or healthy controls. Anxious patients are also more likely to 
experience non-cardiac chest pain (White et al, 2010). Other evidence supports the influence of 
anxiety and depression on health service use, but the direction of this effect is not clear or necessarily 
consistent. For example, some studies have shown that anxiety and depression in cardiac patients 
predict poor attendance at rehabilitation and increased hospital readmissions (Tully et al, 2008; 
Deskur-Śmielecka et al, 2009). However, this latter finding may be partly due to increased morbidity, 
rather than psychological distress per se. Similarly, anxiety and depression may have different effects 
on service use. For example, one study found that length of stay in hospital after coronary artery 
bypass graft surgery was longer in patients with depression but shorter in those with PTSD symptoms 
(Oxlad et al, 2006). 
 
In terms of the impact on rehabilitation and ability to make appropriate lifestyle changes, there is 
some evidence that anxiety is associated with poor adherence to dietary advice and other aspects of 
rehabilitation (Kuhl et al, 2009; Luyster et al, 2009).  A study of anxiety in 278 MI patients found that 
anxiety was associated with less change in socializing, smoking cessation or stress management four 
months after MI, even after controlling for demographic, cardiovascular and other psychological 
variables (Kuhl et al, 2009).  However further research in this area is required as the evidence is 
inconsistent and most research in this area has looked more generally at anxiety and depression 
combined.   
 
Post-traumatic stress disorder and heart disease 
The majority of research into anxiety and heart disease has focused on symptoms of anxiety, as 
measured by self report questionnaires, rather than classifying the presence of anxiety disorders.  
While this approach has merit, consideration of the full range of anxiety disorders may bring to light 
presentations and clusters of symptoms that otherwise go undetected in heart disease. Anxiety 
disorders include generalized anxiety disorder, panic, phobias, obsessive-compulsive disorder and 
posttraumatic stress disorder (PTSD).  Of these, there has been increasing interest in the occurrence 
of PTSD following cardiac events (Owen et al, 2001; Spindler and Pedersen, 2005; Ginzberg, 2006). 
PTSD is an anxiety disorder that occurs when people experience a life-threatening event during which 
they feel intense fear or helplessness. Diagnostic criteria for PTSD are shown in Table 1. 
 
Like other anxiety disorders, PTSD is a risk factor for the development of heart disease and other 
illnesses. Epidemiological studies of war veterans show those with PTSD report more circulatory, 
digestive, nervous, respiratory and musculoskeletal diseases (Boscarino, 1997), and are at greater 
risk of cardiovascular disease, cancer and all-cause mortality (Boscarino, 2006). PTSD symptoms 
appear to have a dose-response effect on cardiovascular disease. In other words, it is not necessary 
for a person to reach diagnostic criteria for PTSD - even low and moderate symptoms increase risk of 
heart disease (see Kubzansky and Koenen (2009) for an overview). For example, a prospective study 
found that women with five or more symptoms of PTSD were three times more likely to develop heart 
disease, even after controlling for risk factors such as diabetes, smoking, hypertension, anxiety and 
depression (Kubzansky et al, 2009). 
 
In cardiac patients, PTSD is most likely to occur after severe events with sudden onset, such as MI or 
cardiac arrest. PTSD may also be related to the traumatizing nature of some medical treatments, 
such as resuscitation. For example, patients in intensive care units report a variety of psychological 
consequences such as confusion, fragmented recall of events, nightmares and hallucinations, which 
can increase vulnerability to PTSD (Jones et al, 2001). Reviews of PTSD following MI report 
prevalence rates of up to 22%, with an average prevalence of around 15% (Spindler and Pedersen, 
2005; Gander and von Känel, 2006). Up to another 18% of people may experience subclinical levels 
of PTSD symptoms (Ayers et al, 2009).  
 
Research into PTSD after a range of health events shows there is very little association between 
severity of injury or disease and PTSD (Tedstone and Tarrier, 2003). This also appears to be the case 
after MI, where PTSD is best predicted by factors such as perceived severity of MI, feelings of 
helplessness, fear of dying, and young age (Rocha et al, 2008; Guler et al, 2009; Wiedemar et al, 
2009).  
 
Many people who have PTSD symptoms immediately after an MI will recover without treatment. 
Studies of PTSD in other populations have shown that up to half of people with symptoms 
immediately after the event recover without intervention in the first three months. A study of rape 
victims found that although 94% met symptom criteria for PTSD 2 weeks after rape this decreased to 
47% 3 months after the assault (Rothbaum and Foa, 1993). The same has been found in longitudinal 
studies of PTSD in medical populations such as women after pregnancy loss or stillbirth (Englehard et 
al, 2001; Turton et al, 2001).  
 
The coping strategies used by individuals following trauma is thought to be critical in determining 
whether PTSD symptoms resolve (Ehlers and Clark, 2000).  This is demonstrated in MI patients.  
Ayers et al (2009) found the strongest predictors of PTSD symptoms after MI were if the patient had a 
history of psychological problems, believed the MI had negative consequences (e.g. problems in 
relationships or dealing with medication and self-care) and used dysfunctional coping techniques (e.g. 
trying to numb emotions, distract themselves from upsetting thoughts). These factors were more 
strongly associated with PTSD than perceived severity of the MI. 
 
If PTSD does not resolve, symptoms may have a significant impact on the psychological and physical 
wellbeing of MI patients. PTSD is associated with impaired social functioning, poor physical health 
(Ginzburg et al, 2003), increased psychological distress, depression, anxiety, somatic complaints 
(Ginzburg, 2006; Chung et al, 2008), and decreased quality of life (Cohen et al, 2009). Approximately 
half of people who develop PTSD after MI may also develop depression (Ginzburg, 2006). There is 
some evidence that the combination of both anxiety and depression leads to an even poorer 
prognosis for patients with heart disease (Doering et al, 2010).  
 
Less research has looked at the effect of PTSD on prognosis. The few studies that are available 
suggest PTSD is associated with increased reports of cardiovascular symptoms, physical limitations, 
readmission and mortality (Shemesh et al, 2004; Ladwig et al, 2008; Cohen et al, 2009) but not 
necessarily with differences in measurable physiological parameters such as left ventricular ejection 
fraction (LVEF) (Ladwig et al, 2008).  For example, a study of more than 1000 people with heart 
disease found physical limitations and self-reported cardiovascular health were more strongly 
predicted by PTSD than by physical measures of cardiovascular health such as LVEF or inducible 
ischaemia (Cohen et al, 2009). A long-term follow up of patients with implanted cardioverter-
defibrillators showed that patients with PTSD were 3.5 times more likely to die over 5 years, even 
after controlling for age, sex, diabetes, medication, LVEF, depression and anxiety (Ladwig et al, 2008). 
 Clinical implications 
The potential impact of anxiety and PTSD suggests a number of important implications for the 
screening and management of cardiac patients, both in cardiac services and primary care.   
 
Screening 
Identifying patients who may benefit from psychological intervention is a key task for healthcare 
professionals involved in care of cardiac patients (Janeway, 2009). National Institute for Health and 
Clinical Excellence (NICE) guidelines (Cooper et al, 2007), the British Heart Foundation (National 
Audit of Cardiac Rehabilitation team, 2009), and the Department of Health’s National Service 
Framework (NSF) (DH, 2000) all emphasize the need to identify potential psychological 
consequences of heart disease, such as anxiety and depression. Indeed, the NSF outlines that 
patients should be offered an assessment of their physical, psychological and social needs for cardiac 
rehabilitation, before discharge from hospital. 
 
Various self-report instruments are available to screen for anxiety (Janeway, 2009) that are a practical 
and cost effective. For example, a screening tool for psychological distress (STOP-D) has been 
designed specifically for use in cardiology settings (Young et al, 2007). This is a brief 5-item measure 
where patients rate their levels of depression, anxiety, stress, anger and support. Healthcare 
professionals can administer such screening tools and when patients’ scores indicate high levels of 
anxiety or other distress, this can be followed up with a discussion with the patient on the exact nature 
of his/her symptoms. 
 
It is unlikely to be helpful to screen all patients for PTSD or to use PTSD-specific measures. Notable 
PTSD symptoms include distressing dreams, intrusive recollections of the cardiac event and/or its 
treatment, feeling as if the event is reoccurring and distress when reminded of the event.  Healthcare 
professionals may need to ask about the occurrence of such symptoms if patients report high levels of 
anxiety on self-report questionnaire or in general discussion.   
 
 
Management 
In mild-to-moderate cases of anxiety, including PTSD, information giving and reassurance about the 
symptoms experienced can be helpful, especially in the early stages after a cardiac event. If patients 
are able to understand and normalize their symptoms they are less likely to ruminate about the 
meaning of their symptoms and use dysfunctional coping strategies, both of which are associated with 
the development and maintenance of anxiety symptoms.  
 
Cardiac rehabilitation (CR) is recommended for patients following MI and is widely recognized as 
resulting in decreased morbidity and mortality (Eshah and Bond, 2009). Information about coping with 
anxiety can be, and often is, incorporated into CR sessions.  In addition cardiac rehabilitation 
sessions can provide advice regarding lifestyle changes and social support. However, uptake of CR is 
often poor (National Audit of Cardiac Rehabilitation team, 2009).  Health professionals are well placed 
to raise awareness of the benefits of CR and promote attendance. 
 
Partners of patients who have suffered an MI often experience feelings of distress (Joekes et al, 
2005). There are no data on how PTSD in cardiac patients affects partners, although it is reasonable 
to assume this may be an additional source of tension for partners/carers.  This may be significant as 
perceived social support has been shown to be a factor in the development of PTSD symptoms 
(Bisson, 2007).   
 
Onward referral 
When anxiety symptoms persist and are significantly affecting an individual, further support is 
required.  The recommended treatment for many anxiety disorders —including PTSD—is 
psychological therapy. Cognitive behaviour therapy (CBT) or eye movement desensitization 
reprocessing (EMDR) are recommended by the NICE guidelines (National Collaborating Centre for 
Mental Health, 2005) as effective forms of intervention for PTSD.   
 
For moderate symptoms of anxiety or PTSD it may be feasible to treat people in primary care and 
GPs can refer to an appropriate local service. Severe symptoms of anxiety or PTSD require referral to 
adult mental health services or specialist PTSD services.  However, it should be emphasized that 
patients who are distressed by a cardiac event may find it difficult to engage with mental health 
services due to concerns about stigma. In addition mental health services may not be best placed to 
support cardiac patients with their concerns. It is often helpful for cardiac services to make links with 
psychologists and psychiatrists who are experienced with both mental health and physical health 
difficulties.  
 
Conclusions 
In conclusion, research clearly shows that anxiety symptoms, including PTSD, are a risk factor for the 
development of heart disease and are associated with further morbidity in cardiac patients. Screening 
and treatment for anxiety is therefore critical in cardiac settings and primary care. The information 
available so far, as outlined in this article, suggests that appropriate management of anxiety, including 
PTSD, should lead to increased quality of life and reduced morbidity or mortality for these patients. 
However, this has yet to be evaluated or confirmed by research. 
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 Table 1. DSM-IV criteria for PTSD (American Psychiatric Association, 1994) 
Criteria   
Event    Must involve threatened death, serious injury or threat to 
physical integrity of self or other 
   Individual must respond with intense fear, helplessness or 
horror 
 
Symptoms Re-experiencing 
1 or more: 
 Recurrent and intrusive distressing recollections of the 
event 
   Recurrent distressing dreams of the event 
   Acting or feeling as if the event were recurring (e.g. 
flashbacks, hallucinations) 
   Intense psychological distress when exposed to 
reminders of the event 
   Physiological reactivity when exposed to reminders of the 
event 
 
 
 
Avoidance & Numbing 
3 or more: 
 Efforts to avoid thoughts, feelings, or conversations 
associated with the event 
   Efforts to avoid activities, places, or people that will 
remind them of the event 
   Inability to recall some aspects of the event 
   Diminished interest or participation in significant activities 
   Feeling of detachment or estrangement from others 
   Restricted range of affect 
   Sense of foreshortened future 
 
 Arousal  Difficulty falling or staying asleep 
 2 or more:  Irritability or outbursts of anger 
   Difficulty concentrating 
   Hypervigilance 
   Exaggerated startle response 
 
Duration 
  
1 month or more 
 
Disability 
  
Symptoms cause clinically significant distress or impaired 
functioning 
 
